Guillain–Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections.

2013年2月1日 · Diagnostic criteria for GBS include progressive, relatively symmetrical weakness with decreased or absent myotatic reflexes; symptoms must reach maximal intensity within four weeks of onset and...

GBS usually begins abruptly with distal, relatively symmetrical onset of paraesthesias and quickly followed by progressive limb weakness. Progression is rapid, with 50% of patients reaching clinical nadir by 2 weeks and more than 90% by 4 weeks. The current diagnostic criteria include <4 weeks of progression to clinical nadir.

2023年10月10日 · Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy. Symptoms may vary greatly in presentation and severity. Besides weakness and sensory disturbances, patients may have cranial nerve involvement, respiratory insufficiency, autonomic dysfunction and …

2019年11月8日 · Guillain-Barré syndrome (GBS) is a rare but serious post-infectious immune-mediated neuropathy. It results from the autoimmune destruction of nerves in the peripheral nervous system causing symptoms such as numbness, tingling, and weakness that …

2022年7月6日 · Guillain Barre Syndrome (GBS) refers to a group of acute, autoimmune polyneuropathies. This chapter is predominantly about AIDP, AMAN, and AMSAN – since these are most often encountered in the ICU.

2019年9月20日 · Guillain–Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections.